Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Enabling Genomic Technologies and Screening Asia

11 Sep 2014 - 12 Sep 2014 - Singapore, Asia



Bookmark and Share


Select Biosciences South East Asia is delighted to announce that our Enabling Genomic Technologies and Screening Asia Conference and Exhibition will take place at the Biopolis, Singapore on the 11th and 12th September 2014. 

We are co-hosting the event with The Genome Institute of Singapore (GIS) at A*STAR’s state of the art conference facilities within the Biopolis, the Biomedical Science hub for Singapore. 

The event will have two concurrent conference tracks, with presentations from the leading scientists within these fields. The first conference track will cover Enabling Genomic Technologies and we are proud to welcome Dr. Kosuke Yusa as our Keynote Speaker for the meeting. Dr. Kosuke Yusa is a member of the Sanger Institute Faculty, UK.

We are also pleased to welcome both Dr. Ramanuj DasGupta, Group Leader/Senior Investigator, GIS, Cancer Therapeutics & Stratified Oncology, Assoc. Professor, NYU Cancer Institute and Dr. Pauline Ng, Group Leader/Senior Investigator, GIS, Chief Informatics Officer, Polaris. They will be representing our partner, The Genome Institute Singapore (GIS).  

The second track is entitled Screening Asia and we are privileged to have Dr. Alex Matter, M.D., Professor David Virshup and Dr. Litao Zhang, as our Keynote Speakers. 

Dr. Matter is the CEO of the Experimental Therapeutics Centre, A*STAR, Singapore. Professor Virshup is the inaugural Director of the Cancer and Stem Cell Biology Program at the Duke-NUS Graduate Medical School in Singapore. Dr Litao Zhang is the Vice President of Leads Discovery and Optimization, Bristol-Myers Squibb.

Attending this meeting will give you an excellent opportunity for networking with like-minded peers, helping you to find unique solutions and build long term collaborations. With all delegates having full access to both conference tracks, everyone has the opportunity to develop the specific agenda of their choice. 

Select Biosciences South East Asia is looking forward to welcoming you to this exciting event, and we hope that your experience will be both informative and enjoyable.



Further information
Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!